MedPath

Multimorbidity, patient orientation, health literacy and ethical aspects in the long-term perspective of patients with implants

Conditions
Implants for prelingual or postlingual deafness, open angle glaucoma, and cardiovascular diseases
Registration Number
DRKS00022755
Lead Sponsor
Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (ceres), University of Cologne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
196
Inclusion Criteria

Glaucoma implants

Group 1: Drug therapy only (drops); adults (= 50 years) with open angle glaucoma; time of diagnosis and start of drug therapy at least 12 months ago; at least 6 months postoperatively after implantation; visual acuity in the better eye = 30%

Group 2: Micro-Stent ± drug therapy (drops); adults (= 50 years) with open angle glaucoma; time of diagnosis and start of drug therapy at least 12 months ago; visual acuity in the better eye = 30%

Written declaration of consent by the patient

German language skills that allow participation in the study

cochlea implants

Group 1: Postlingual deafness and implantation; middle age
Group 2a: Prelingual deafness and childhood implantation
Group 2b: Parents of participants from group 2a

Minimum wearing period of the cochlea implant of 12 months after implantation

Minimum age of 18 years

Written declaration of consent by the patient

German language skills that allow participation in the study

Cardiovascular implants

At least 6 months postoperatively after implant insertion

Minimum age of 18 years

Written declaration of consent by the patient

German language skills that allow participation in the study

Exclusion Criteria

Cognitive or physical limitations that do not allow participation in the study

For glaucoma implants age < 50 years

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Transmitting ethical, psychosocial, cultural and health literacy relevant aspects into the development and provision of implants. Increasing the patient orientation in implant development and provision. Promotion of the quality of life of people with implants. Reduction of the costs of care.
Secondary Outcome Measures
NameTimeMethod
Educational guidelines and best-practice models for doctor-patient communication and for cross-sectoral and inter-professional health care practice. Foundations for preference-sensitive decision-making in the context of implant technologies.
© Copyright 2025. All Rights Reserved by MedPath